Abstract:Synthetic short interfering RNA (siRNA) oligonucleotides can trigger the RNA interference pathway and lead to selective gene silencing. Despite considerable enthusiasm and investment, formidable challenges remain that may deter translating this breakthrough discovery into clinical applications. In particular, the development of efficient, nontoxic, nonimmunogenic methods for delivering siRNA in vivo has proven to be exceptionally challenging. Thorough analysis of the relationship between the structure and function of siRNA carrier systems, both in isolation and in complex with RNA, will facilitate the design of efficient nonviral siRNA delivery vehicles. In this study, we explore the relationship between the physicochemical characteristics and the biological activity of "lipitoid" compounds as potent siRNA delivery vehicles. Lipitoids are cationic peptidomimetic oligomers incorporating a peptoid and a phospholipid moiety. Lipitoids can associate with siRNA oligonucleotides and self-assemble into spherical lipitoid-based nanoparticles (LNPs), with dimensions that are dependent upon the medium and the stoichiometric ratio between the cationic monomers of the lipitoid and anionic siRNA oligonucleotides. The morphology, gene silencing efficiency, and cytotoxicity of the siRNA-loaded LNPs are similarly sensitive to the stoichiometry of the complexes. The medium in which the LNPs are formed affects the assembled cargo particles' characteristics such as particle size, transfection efficiency, and stability. Formation of the LNPs in the biological, serum-free medium OptiMEM resulted in LNPs an order of magnitude larger than LNPs formed in water, and were twice as efficient in siRNA transfection compared to LNPs formed in water. Inhibitor studies were conducted to elucidate the efficiency of lysosomal escape and the uptake mechanism of the siRNA-loaded LNPs. Our results suggest that these lipitoid-based, siRNA-loaded spherical LNPs are internalized through a lipid raft-dependent and dynamin-mediated pathway, circumventing endosomal and lysosomal encapsulation. The lipitoid-siRNA nanospheres proved to be suitable platforms for investigating the critical parameters determining the efficiency of transfection agents, revealing the necessity for conducting characterization studies in biological media. The investigation of the LNP internalization pathway points to an alternative uptake route that bypasses the lysosome, explaining the surprisingly high efficiency of LNPs and suggesting that the uptake mechanism should be probed rather than assumed for the next generation of rationally designed transfection agents.

Novel Lipoidal Amine-Based Nanocarrier Formulations for Sirna Delivery

Lipid-Based Nanoparticles in the Systemic Delivery of Sirna

Lipid Nanoparticle (LNP) Chemistry Can Endow Unique in Vivo RNA Delivery Fates Within the Liver That Alter Therapeutic Outcomes in a Cancer Model

Lipid-Modified Aminoglycoside Derivatives for in Vivo Sirna Delivery

Enhanced Hepatic Delivery of Sirna and Microrna Using Oleic Acid Based Lipid Nanoparticle Formulations

Ε-Caprolactone-modified Polyethylenimine As Efficient Nanocarriers for Sirna Delivery in Vivo.

Lipid‐based nanotherapeutics for siRNA delivery

Insight into Mechanisms of Cellular Uptake of Lipid Nanoparticles and Intracellular Release of Small RNAs

Lipid Nanoparticles for Hepatic Delivery of Small Interfering Rna

Multiparametric Approach For The Evaluation Of Lipid Nanoparticles For Sirna Delivery

Drug Delivery: Lipid‐Modified Aminoglycoside Derivatives for in Vivo Sirna Delivery (adv. Mater. 33/2013)

Synthesis Of Polymer-Lipid Nanoparticles By Microfluidic Focusing For Sirna Delivery

A Nanoconfined Loading Strategy for Highly Efficient Sirna Delivery and Cancer Therapy

Nanometer-scale siRNA carriers incorporating peptidomimetic oligomers: physical characterization and biological activity

Polymeric‐Micelle‐Based Nanomedicine for Sirna Delivery

Hybrid Lipid–polymer Nanoparticles for Sustained Sirna Delivery and Gene Silencing

Efficient Systemic Delivery Of Sirna By Using High-Density Lipoprotein-Mimicking Peptide Lipid Nanoparticles

Systemic Delivery of Sirna with Cationic Lipid Assisted PEG-PLA Nanoparticles for Cancer Therapy.

Mechanistic Insights into LDL Nanoparticle-Mediated Sirna Delivery.

Microfluidic-Based Holonomic Constraints of Sirna in the Kernel of Lipid/Polymer Hybrid Nanoassemblies for Improving Stable and Safe in Vivo Delivery

Comparative Cellular Pharmacokinetics and Pharmacodynamics of Sirna Delivery by SPANosomes and by Cationic Liposomes.